When given intraperitoneally (i.e., 10 g/kg b.w.), NaBPC157 was shown to prevent the development of alloxan as well as streptozotocin induced diabetes in rats
Frequency: Administer once daily via subcutaneous injection
Through its calming effect on the nervous system, it may help ease headaches, migraines, and tension-related discomfort
There are a few different points of view on why this treatment is important
They are: Contaminated or mislabelled compounded products research-grade vs pharmaceutical-grade manufacturing matters enormously Incorrect dosing without clinical oversight, patients routinely underdose (no effect) or overdose (unknown risk) Drug interactions particularly relevant if you are on GLP-1 therapy, immunosuppressants, or anti-inflammatory medications
Notably, a consistent trend of declining serum BDNF levels has been linked to the progression of chronic substance use [3]